Enzybiotics LYSSTAPH-S and LYSDERM-S as Potential Therapeutic Agents for Chronic MRSA Wound Infections

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68081715%3A_____%2F20%3A00531787" target="_blank" >RIV/68081715:_____/20:00531787 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14110/20:00116414 RIV/00159816:_____/20:00073251 RIV/00027162:_____/20:N0000072
Result on the web
<a href="http://hdl.handle.net/11104/0310404" target="_blank" >http://hdl.handle.net/11104/0310404</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3390/antibiotics9080519" target="_blank" >10.3390/antibiotics9080519</a>

Result language
angličtina
Original language name
Enzybiotics LYSSTAPH-S and LYSDERM-S as Potential Therapeutic Agents for Chronic MRSA Wound Infections
Original language description
Antistaphylococcal enzymes derived from lysostaphin and endolysin were modified in order to improve their antimicrobial properties and stability. These antimicrobial enzymes proved to be efficient in killing of the diverse strains of methicillin-resistant Staphylococcus aureus.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10406 - Analytical chemistry

Project
<a href="/en/project/NV19-05-00214" target="_blank" >NV19-05-00214: Study of therapeutic application of antibacterial wound dressing for skin and soft tissue infections in epidemiologically relevant strains of S. aureus - methicillin resistant.</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)